Want to see AU:NOX full AI Analyst Report?
Noxopharm Ltd. (NOX) Financial Statements
Noxopharm Ltd. Financial Overview
Noxopharm Ltd.'s market cap is currently $15.05M. The company's EPS TTM is $-0.02; its P/E ratio is -3.20; Noxopharm Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.43M | $ 2.82M | $ 2.40M | $ 6.01M | $ 5.43M |
| Gross Profit | $ -1.74K | $ -1.45M | $ -534.81K | $ 5.86M | $ 5.17M |
| Operating Income | $ -4.85M | $ -9.65M | $ -7.54M | $ -16.60M | $ -15.21M |
| EBITDA | $ -4.85M | $ -5.38M | $ -5.95M | $ -20.85M | $ -23.70M |
| Net Income | $ -4.46M | $ -4.88M | $ -3.58M | $ -15.06M | $ -18.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 293.57K | $ 1.55M | $ 2.32M | $ 3.01M | $ 14.01M |
| Total Assets | $ 1.84M | $ 4.58M | $ 6.78M | $ 10.13M | $ 26.59M |
| Total Debt | $ 4.57M | $ 2.48M | $ 0.00 | $ 0.00 | $ 160.62K |
| Net Debt | $ 4.28M | $ 924.99K | $ -2.32M | $ -3.01M | $ -13.85M |
| Total Liabilities | $ 5.48M | $ 3.89M | $ 1.29M | $ 1.06M | $ 2.48M |
| Stockholders' Equity | $ -3.65M | $ 689.96K | $ 5.50M | $ 9.07M | $ 24.12M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.71M | $ -5.82M | $ -684.31K | $ -10.95M | $ -13.73M |
| Operating Cash Flow | $ -2.71M | $ -5.82M | $ -684.31K | $ -10.95M | $ -13.73M |
| Investing Cash Flow | $ 0.00 | $ 2.48M | $ 0.00 | $ 123.51K | $ 0.00 |
| Financing Cash Flow | $ 1.45M | $ 2.60M | $ 0.00 | $ -178.09K | $ 975.73K |
Currency in AUD